MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement
It is an open study, explorative, proof of concept study concerning mycobiota dysbiosis implication in AD patients with head and neck involvement.
• Age between 18 and 65 years;
• Male or female;
• The diagnosis of atopic dermatitis (AD) is defined according to the criteria of UK Working Party with at least 3 of the following 5 criteria are present; history of flexural involvement, history of a dry skin, onset under the age of 2, personal history of asthma or allergic rhinitis, history of a pruritic skin condition, and visible flexural dermatitis.
• Generalized AD defined by AD involved ≥50% of total body surface area with head and neck involvement. Or HNAD defined by AD involving at least 80% of the head and neck area with or without AD involvement outside the head and neck area but \<20% of total body surface area.
• With topical anti-inflammatory treatments for AD (including; topical steroids and/or topical tacrolimus)
• Free, informed and written consent, signed by the patient and the investigator before any examination required by the trial;
• Affiliation to social security scheme (beneficiary or assignee)
• Healthy control are the same age and sex.